About Noven
Noven Pharmaceuticals, Inc. (Noven) is a specialty pharmaceutical company engaged in the research, development, manufacturing, licensing, marketing and sale of prescription pharmaceutical products. Its business is focused in three segments: Noven Transdermals, its transdermal drug delivery segment; Novogyne Pharmaceuticals (Novogyne), its women’s – more... health joint venture with Novartis Pharmaceuticals Corporation (Novartis), and Noven Therapeutics, its specialty pharmaceutical segment. The Company’s primary commercialized products include prescription transdermal patches utilizing its proprietary transdermal drug delivery technology for use in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and in menopausal hormone therapy. In August 2009, Hisamitsu Pharmaceutical Co., Ltd. and Hisamitsu U.S., Inc. announced the completion of their acquisition of Noven. As a result of the transaction, Noven became a wholly owned subsidiary of Hisamitsu U.S., Inc. – less – More from ZoomInfo »
